Zenobia Therapeutics
San Diego, United States· Est. 2019
Develops antibody-drug conjugates targeting solid tumors with novel payload technologies.
Private Company
Total funding raised: $30M
About
Develops antibody-drug conjugates targeting solid tumors with novel payload technologies.
OncologyAntibodies
Funding History
2Total raised:$30M
Series A$25MMar 15, 2022
Seed$5MSep 15, 2020